首页> 美国卫生研究院文献>other >The use of fenestrated and branched endovascular aneurysm repair for juxtarenal and thoracoabdominal aneurysms: a systematic review and cost-effectiveness analysis.
【2h】

The use of fenestrated and branched endovascular aneurysm repair for juxtarenal and thoracoabdominal aneurysms: a systematic review and cost-effectiveness analysis.

机译:开窗和分支血管内动脉瘤修复术在近鼻和胸腹动脉瘤中的应用:系统评价和成本效益分析。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUNDPatients with large abdominal aortic aneurysms (AAAs) are usually offered reparative treatment given the high mortality risk. There is uncertainty about how to treat juxtarenal AAAs (JRAAAs) or thoracoabdominal aortic aneurysms (TAAAs). Endovascular repair of an abdominal aortic aneurysm (EVAR) is often seen as safer and easier than open surgical repair (OSR). However, endovascular treatment of JRAAAs or TAAAs requires specially manufactured stent grafts, with openings to allow blood to reach branches of the aorta. Commissioners are receiving increasing requests for fenestrated EVAR (fEVAR) and branched EVAR (bEVAR), but it is unclear whether or not the extra cost of fEVAR or bEVAR is justified by advantages for patients.
机译:背景技术鉴于高死亡率风险,通常会为腹部大动脉瘤(AAAs)大的患者提供修复治疗。关于如何治疗近肾AAA(JRAAA)或胸腹主动脉瘤(TAAA)存在不确定性。腹主动脉瘤(EVAR)的血管内修复通常比开放式手术修复(OSR)更安全,更容易。但是,JRAAAs或TAAAs的血管内治疗需要专门制造的支架移植物,其开口允许血液到达主动脉分支。委员们对开窗式EVAR(fEVAR)和分支EVAR(bEVAR)的要求越来越高,但尚不清楚fEVAR或bEVAR的额外费用是否因患者的利益而合理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号